While new diagnoses of diabetes in adults have slowed in recent years, the pandemic may reverse this trend. Physicians, payers, and pharmaceutical companies all can play a part in mitigating the long-term effects on persons with diabetes. Precision’s Cynthia Miller details how these stakeholders can collaborate to mitigate future damage.

Read the full article here!